// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

RECEIVER trial: sustained use and improved outcomes with digitally supported COPD co-management

Chris Carlin - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Feasibility of smartphone-based physical activity tele-coaching in lung transplant recipients

Emily Hume - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A systematic review to assess the components of clinical decision support systems (CDSS) in chronic respiratory disease (CRD) and their relevance to physiotherapy management

Katherine O'Neill - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Automatic lung sound analysis accuracy: a validation study

Olga Kharevich - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Barriers and enablers of attendance to a virtual pulmonary rehabilitation programme

Maria Koulopoulou - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Early supported discharge of COVID-19 patients with home oxygen therapy

Rosie Harkness - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Vironix: remote screening, detection, and triage of viral respiratory illness via cloud-enabled, machine-learned APIs

Sumanth Swaminathan - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Fully automated airway measurement correlates with radiological disease progression in Idiopathic Pulmonary Fibrosis

Michael Roberts - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Transcriptome profiling reveals a potential role for antagonism of the calcium-sensing receptor in the prophylaxis of idiopathic pulmonary fibrosis

Kasope L. Wolffs - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Glutamine

Treatment of early undiagnosed airflow obstruction in patients of OSA on CPAP improves sleep quality and symptoms

Tarang Kulkarni - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

Seebri Breezhaler

Observational study of ivacaftor in people with cystic fibrosis and selected non-G551D gating mutations: final results from VOCAL

Nicholas Simmonds - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

Ivacaftor

The Palestinian primary ciliary dyskinesia (PCD) cohort: clinical, diagnostic and genetic spectrum

Nisreen Rumman - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Primary ciliary dyskinesia

Nitric oxide

A case-control study on direct oral anticoagulants versus warfarin for acute pulmonary embolism in obese patients

Chinthaka Samaranayake - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary embolism

Warfarin

Sildenafil for treatment of associated pulmonary hypertension in patients with severe COVID-19 pneumonia

Irfan Qamar - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Severe COVID-19 pneumonia

Sildenafil citrate

Nitrofurantoin Induced Pulmonary Fibrosis: A Case Series

Samiha Naureen - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Urinary tract infections

Nitrofurantoin

A single centre study of COVID-19 patients: correlation with DDIMER and outcomes

Indrajit Sau - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

SJ8903

The respiratory tract of patients with antibody deficiency on immunoglobulin replacement is characterised by inflammation and dysbiosis despite adequate levels of sputum IgG

Anna Schnell - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Dysbiosis

Intratect

Mapping inflammatory endotypes of bronchiectasis associated with impaired mucociliary clearance

Mathieu Bottier - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Systemic inflammation

IL-4

The relationship between thyroid function and lipid metabolomics and response to combination thyroid hormone replacement

Peter Taylor - European Thyroid Association (ETA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Levothyroxine

Selenoprotein deficiency disorder predisposes to aortic aneurysm formation

Erik Schoenmakers - European Thyroid Association (ETA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Selenium

Copyright © 2026. QuantiNova All rights reserved